iptacopan
iptacopan is listed in the FDA National Drug Code directory with 4 NDC codes, marketed under brand name including FABHALTA. Available dosage forms: capsule, powder.
Drug details
- Generic Name
- iptacopan
- Brand Names
- FABHALTA
- Application Number
- NDA218276
- Sponsor
- Novartis Pharmaceuticals Corporation
- NDC Codes
- 4
- Dosage Forms
- CAPSULE, POWDER
- Routes
- ORAL
- Active Ingredients
- IPTACOPAN HYDROCHLORIDE
Indications and Usage
1 INDICATIONS AND USAGE FABHALTA is a complement factor B inhibitor, indicated for: the treatment of adults with paroxysmal nocturnal hemoglobinuria (PNH). ( 1.1 ) slowing kidney function decline in adults with primary immunoglobulin A nephropathy (IgAN) at risk of disease progression. ( 1.2 ) the treatment of adults with complement 3 glomerulopathy (C3G), to reduce proteinuria. ( 1.3 ) 1.1 Paroxysmal Nocturnal Hemoglobinuria FABHALTA is indicated for the treatment of adults with paroxysmal nocturnal hemoglobinuria (PNH). 1.2 Immunoglobulin A Nephropathy FABHALTA is indicated to slow kidney function decline in adults with primary immunoglobulin A nephropathy (IgAN) at risk of disease progression. 1.3 Complement 3 Glomerulopathy FABHALTA is indicated for the treatment of adults with complement 3 glomerulopathy (C3G), to reduce proteinuria.